Vipin K Garg's Net Worth
$5.43 Million
Who is Vipin K Garg?
Vipin K Garg has an estimated net worth of $5.43 Million. This is based on reported shares across multiple companies, which include Altimmune, Inc., Neos Therapeutics, Inc., and TRANZYME INC.
SEC CIK
Vipin K Garg's CIK is 0001515813
Past Insider Trading and Trends
2023 was Vipin K Garg's most active year for acquiring shares with 6 total transactions. Vipin K Garg's most active month to acquire stocks was the month of December. 2022 was Vipin K Garg's most active year for disposing of shares, totalling 15 transactions. Vipin K Garg's most active month to dispose stocks was the month of January. 2019 saw Vipin K Garg paying a total of $42,000.00 for 20,000 shares, this is the most they've acquired in one year. In 2022 Vipin K Garg cashed out on 91,628 shares for a total of $1,008,434.77, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Altimmune, Inc. (ALT) Snapshot price: $10.376
President and CEOVipin K Garg owns 292,028 units of Common Stock, par value $0.0001 which is worth $3,030,082.53. From 2018 to 2024 Vipin K Garg acquired a total of 493,946 shares in Altimmune, Inc. at a cost of $148,606.24, Vipin also disposed a total of 201,918 shares of Altimmune, Inc. equalling to $2,193,848.39.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.28% | 19.81K |
$9.58 | -$150,316.76 | 292.03K |
Feb 1 - Feb 2
| |||
Form 4
| +9.21% | 22.97K |
$6.25 | -$93,409.19 | 272.22K |
Jan 30 - Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| +0.05% | 126 |
$2.81 | $354.06 | 249.25K |
Jul 31
| |||
Form 4
| +4.41% | 10.53K |
$15.04 | -$126,666.88 | 249.13K |
Feb 2
| |||
Form 4
| +4.75% | 10.83K |
$12.00 | -$85,743.17 | 238.6K |
Jan 31 - Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
| -1.30% | -3.01K |
$9.95 | -$29,919.65 | 227.78K |
Nov 30
| |||
Form 4
| -1.29% | -3.01K |
$12.77 | -$38,399.39 | 230.78K |
Oct 30
| |||
Form 4
| -1.27% | -3.01K |
$12.77 | -$38,412.16 | 233.79K |
Sep 30
| |||
Form 4
| -8.86% | -23.01K |
$19.88 | -$457,274.58 | 236.8K |
Scheduled
|
Aug 30 - Aug 31
| ||
Form 4
| -5.46% | -15.00K |
$15.06 | -$225,889.50 | 259.8K |
Scheduled
|
Aug 12
| ||
Form 4
| -1.08% | -3.01K |
$12.01 | -$36,114.07 | 274.8K |
Jul 30
| |||
Form 4
| -1.07% | -3.01K |
$11.70 | -$35,181.90 | 277.81K |
Jun 30
| |||
Form 4
| -1.06% | -3.01K |
$5.03 | -$15,130.24 | 280.82K |
May 30
| |||
Form 4
| -1.05% | -3.01K |
$4.52 | -$13,596.16 | 283.83K |
Apr 30
| |||
Form 4
| -1.04% | -3.01K |
$6.05 | -$18,192.35 | 286.83K |
Mar 30
| |||
Form 4
| -1.03% | -3.01K |
$7.41 | -$22,281.87 | 289.84K |
Feb 28
| |||
Form 4
| +4.14% | 11.65K |
$7.42 | -$42,173.88 | 292.85K |
Jan 31 - Feb 2
| |||
Form 4
| -0.83% | -2.35K |
$7.20 | -$16,956.00 | 281.2K |
Jan 30
| |||
Form 4
| -1.05% | -3.01K |
$8.93 | -$26,852.51 | 283.56K |
Dec 30
| |||
Form 4
| -1.04% | -3.01K |
$10.49 | -$31,543.43 | 286.56K |
Nov 30
| |||
Form 4
| -1.03% | -3.01K |
$10.80 | -$32,475.60 | 289.57K |
Oct 30
| |||
Form 4
| -1.02% | -3.01K |
$11.31 | -$34,009.17 | 292.58K |
Sep 30
| |||
Form 4
| -1.01% | -3.01K |
$14.09 | -$42,382.72 | 295.58K |
Aug 30
| |||
Form 4
| -1.00% | -3.01K |
$9.07 | -$27,273.49 | 298.59K |
Jul 30
| |||
Form 4
| -0.99% | -3.01K |
$9.85 | -$29,618.95 | 301.6K |
Jun 30
| |||
Form 4
| -0.84% | -2.58K |
$12.65 | -$32,599.05 | 304.61K |
May 30
| |||
Form 4
| -0.65% | -2.00K |
$14.47 | -$28,925.53 | 307.18K |
Apr 30
| |||
Form 4
| -0.64% | -2.00K |
$13.55 | -$27,072.90 | 309.18K |
Mar 30
| |||
Form 4
| -0.64% | -2.00K |
$15.94 | -$31,848.12 | 311.18K |
Feb 28
| |||
Form 4
| +0.34% | 1.05K |
$12.14 | $12,807.70 | 313.18K |
Jan 31 - Feb 1
| |||
Form 4
| -0.75% | -2.35K |
$14.28 | -$33,600.84 | 312.12K |
Jan 30
| |||
Form 4
| -0.95% | -3.02K |
$11.30 | -$34,182.50 | 314.48K |
Dec 30
| |||
Form 4
| -0.70% | -2.24K |
$12.23 | -$27,431.89 | 317.5K |
Nov 30
| |||
Form 4
| -0.63% | -2.02K |
$11.45 | -$23,071.75 | 319.74K |
Oct 30
| |||
Form 4
| -0.62% | -2.02K |
$13.20 | -$26,598.00 | 321.76K |
Sep 30
| |||
Form 4
| -0.62% | -2.02K |
$17.62 | -$35,504.30 | 323.77K |
Aug 30
| |||
Form 4
| +3.72% | 11.67K |
$1.46 | $17,044.04 | 325.79K |
Jul 31
| |||
Form 4
| -0.64% | -2.02K |
$26.06 | -$52,510.90 | 314.12K |
Jul 30
| |||
Form 4
| -0.63% | -2.02K |
$10.71 | -$21,580.65 | 316.13K |
Jun 30
| |||
Form 4
| -0.63% | -2.02K |
$9.28 | -$18,699.20 | 318.14K |
May 30
| |||
Form 4
| -0.63% | -2.02K |
$3.05 | -$6,145.75 | 320.16K |
Apr 30
| |||
Form 4
| -0.62% | -2.02K |
$3.02 | -$6,088.32 | 322.18K |
Mar 31
| |||
Form 4
| -0.62% | -2.02K |
$3.70 | -$7,455.50 | 324.19K |
Feb 29
| |||
Form 4
| +3.58% | 11.29K |
$1.46 | $16,481.94 | 326.21K |
Jan 31
| |||
Form 4
| -0.64% | -2.02K |
$1.77 | -$3,566.55 | 314.92K |
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| -0.63% | -2.00K |
$1.80 | -$3,598.20 | 316.93K |
Dec 30
| |||
Form 4
| -6.99% | -23.98K |
$1.82 | -$43,636.32 | 318.93K |
Nov 30
| |||
Form 4
| +6.19% | 20K |
$2.10 | $42,000.00 | 342.91K |
Sep 5
| |||
Form 4
|
∞
| 322.91K |
—
|
—
| 322.91K |
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neos Therapeutics, Inc. No price found
Chief Executive OfficerVipin K Garg owns 160,748 units of Common Stock. From 2015 to 2018 Vipin K Garg acquired a total of 52,500 shares in Neos Therapeutics, Inc., Vipin also disposed a total of 33,801 shares of Neos Therapeutics, Inc. equalling to $351,518.71.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +18.42% | 25K |
—
|
—
| 160.75K |
Mar 1
| |||
Form 4
| -9.89% | -14.89K |
$8.00 | -$119,160.00 | 135.75K |
Oct 16
| |||
Form 4
| +19.90% | 25K |
—
|
—
| 150.64K |
May 1
| |||
Form 4
| -7.17% | -9.71K |
$6.37 | -$61,846.33 | 125.64K |
Oct 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| -6.36% | -9.20K |
$18.54 | -$170,512.38 | 135.35K |
Oct 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
| +1.76% | 2.5K |
—
|
—
| 144.55K |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TRANZYME INC No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||